Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
221.1 USD | -0.90% | -5.13% | -6.57% |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.57% | 11.49B | |
+40.67% | 54.04B | |
+43.57% | 41.96B | |
-1.12% | 41.92B | |
-7.59% | 28.35B | |
+12.44% | 26.35B | |
-22.10% | 19B | |
+7.78% | 13B | |
+28.26% | 12.28B | |
+24.89% | 12.19B |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- Transcript : Charles River Laboratories International, Inc., Q3 2020 Earnings Call, Oct 29, 2020